Andrew Booth - 26 May 2023 Form 4 Insider Report for AbCellera Biologics Inc. (ABCL)

Signature
Tryn Stimart, attorney-in-fact
Issuer symbol
ABCL
Transactions as of
26 May 2023
Net transactions value
+$99,325
Form type
4
Filing time
26 May 2023, 14:53:34 UTC
Previous filing
22 Dec 2022
Next filing
16 Jan 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABCL Common Shares Purchase $99,325 +14,500 +10% $6.85 153,000 26 May 2023 Direct
holding ABCL Common Shares 130,959 26 May 2023 By spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.